Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager

Accelerate Diagnostics Inc

NASDAQ:AXDX

Watchlist

Price: 1.47 USD -0.68%

Market Cap: 34.7m USD

Have any thoughts about
Accelerate Diagnostics Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 1.47 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

AXDX Alert

Accelerate Diagnostics Inc

1.47

-0.01 (-0.68%)

52 Week Range	0.7365 6.7
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Accelerate Diagnostics Inc

What unique competitive advantages
does Accelerate Diagnostics Inc hold over its rivals?

What risks and challenges
does Accelerate Diagnostics Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Accelerate Diagnostics Inc.

What unique competitive advantages
does Accelerate Diagnostics Inc hold over its rivals?

What risks and challenges
does Accelerate Diagnostics Inc face in the near future?

Has there been any significant insider trading activity
in Accelerate Diagnostics Inc recently?

Summarize the latest earnings call
of Accelerate Diagnostics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Accelerate Diagnostics Inc.

Provide P/S
for Accelerate Diagnostics Inc.

Provide P/E
for Accelerate Diagnostics Inc.

Provide P/OCF
for Accelerate Diagnostics Inc.

Provide P/FCFE
for Accelerate Diagnostics Inc.

Provide P/B
for Accelerate Diagnostics Inc.

Provide EV/S
for Accelerate Diagnostics Inc.

Provide EV/GP
for Accelerate Diagnostics Inc.

Provide EV/EBITDA
for Accelerate Diagnostics Inc.

Provide EV/EBIT
for Accelerate Diagnostics Inc.

Provide EV/OCF
for Accelerate Diagnostics Inc.

Provide EV/FCFF
for Accelerate Diagnostics Inc.

Provide EV/IC
for Accelerate Diagnostics Inc.

Show me price targets
for Accelerate Diagnostics Inc made by professional analysts.

What are the Revenue projections
for Accelerate Diagnostics Inc?

How accurate were the past Revenue estimates
for Accelerate Diagnostics Inc?

What are the Net Income projections
for Accelerate Diagnostics Inc?

How accurate were the past Net Income estimates
for Accelerate Diagnostics Inc?

What are the EPS projections
for Accelerate Diagnostics Inc?

How accurate were the past EPS estimates
for Accelerate Diagnostics Inc?

What are the EBIT projections
for Accelerate Diagnostics Inc?

How accurate were the past EBIT estimates
for Accelerate Diagnostics Inc?

Compare the revenue forecasts
for Accelerate Diagnostics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Accelerate Diagnostics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Accelerate Diagnostics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Accelerate Diagnostics Inc compared to its peers.

Compare the P/E ratios
of Accelerate Diagnostics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Accelerate Diagnostics Inc with its peers.

Analyze the financial leverage
of Accelerate Diagnostics Inc compared to its main competitors.

Show all profitability ratios
for Accelerate Diagnostics Inc.

Provide ROE
for Accelerate Diagnostics Inc.

Provide ROA
for Accelerate Diagnostics Inc.

Provide ROIC
for Accelerate Diagnostics Inc.

Provide ROCE
for Accelerate Diagnostics Inc.

Provide Gross Margin
for Accelerate Diagnostics Inc.

Provide Operating Margin
for Accelerate Diagnostics Inc.

Provide Net Margin
for Accelerate Diagnostics Inc.

Provide FCF Margin
for Accelerate Diagnostics Inc.

Show all solvency ratios
for Accelerate Diagnostics Inc.

Provide D/E Ratio
for Accelerate Diagnostics Inc.

Provide D/A Ratio
for Accelerate Diagnostics Inc.

Provide Interest Coverage Ratio
for Accelerate Diagnostics Inc.

Provide Altman Z-Score Ratio
for Accelerate Diagnostics Inc.

Provide Quick Ratio
for Accelerate Diagnostics Inc.

Provide Current Ratio
for Accelerate Diagnostics Inc.

Provide Cash Ratio
for Accelerate Diagnostics Inc.

What is the historical Revenue growth
over the last 5 years for Accelerate Diagnostics Inc?

What is the historical Net Income growth
over the last 5 years for Accelerate Diagnostics Inc?

What is the current Free Cash Flow
of Accelerate Diagnostics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Accelerate Diagnostics Inc.

AXDX

Cash Flow Statement

Cash from Investing Activities

Accelerate Diagnostics Inc
Cash from Investing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Accelerate Diagnostics Inc
Cash from Investing Activities Peer Comparison

Comparables:

BDX

BSX

SYK

ABT

ISRG

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

	Cash from Investing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Accelerate Diagnostics Inc NASDAQ:AXDX	Cash from Investing Activities -$975k	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years 24%
Becton Dickinson and Co NYSE:BDX	Cash from Investing Activities -$1.4B	CAGR 3-Years 2%	CAGR 5-Years -11%	CAGR 10-Years -1%
Boston Scientific Corp NYSE:BSX	Cash from Investing Activities -$1.8B	CAGR 3-Years -107%	CAGR 5-Years 5%	CAGR 10-Years -11%
Stryker Corp NYSE:SYK	Cash from Investing Activities -$822m	CAGR 3-Years 44%	CAGR 5-Years 19%	CAGR 10-Years 9%
Abbott Laboratories NYSE:ABT	Cash from Investing Activities -$2.3B	CAGR 3-Years -7%	CAGR 5-Years -6%	CAGR 10-Years -7%
Intuitive Surgical Inc NASDAQ:ISRG	Cash from Investing Activities -$2.1B	CAGR 3-Years 4%	CAGR 5-Years -6%	CAGR 10-Years N/A

What is Accelerate Diagnostics Inc's Cash from Investing Activities?

Cash from Investing Activities
-975k USD

Based on the financial report for Jun 30, 2024, Accelerate Diagnostics Inc's Cash from Investing Activities amounts to -975k USD.

Accelerate Diagnostics Inc
NASDAQ:AXDX

Accelerate Diagnostics Inc
Cash from Investing Activities

Accelerate Diagnostics Inc
Cash from Investing Activities Peer Comparison

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Accelerate Diagnostics Inc's Cash from Investing Activities?

Cash from Investing Activities
-975k USD

What is Accelerate Diagnostics Inc's Cash from Investing Activities growth rate?

Cash from Investing Activities CAGR 10Y
24%

Company

Help

Tools

Stocks

Accelerate Diagnostics Inc NASDAQ:AXDX

Accelerate Diagnostics Inc Cash from Investing Activities

Accelerate Diagnostics Inc Cash from Investing Activities Peer Comparison

Competitive Cash from Investing Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is Accelerate Diagnostics Inc's Cash from Investing Activities? Cash from Investing Activities -975k USD

What is Accelerate Diagnostics Inc's Cash from Investing Activities growth rate? Cash from Investing Activities CAGR 10Y 24%

Company

Help

Tools

Stocks

Accelerate Diagnostics Inc
NASDAQ:AXDX

Accelerate Diagnostics Inc
Cash from Investing Activities

Accelerate Diagnostics Inc
Cash from Investing Activities Peer Comparison

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

What is Accelerate Diagnostics Inc's Cash from Investing Activities?

Cash from Investing Activities
-975k USD

What is Accelerate Diagnostics Inc's Cash from Investing Activities growth rate?

Cash from Investing Activities CAGR 10Y
24%